Skip to main content

Questions about
taking EYSUVIS?

(We were expecting that)

Get rapid* relief with these simple steps:

Step 1

If you’re wearing contact lenses, take them out before using EYSUVIS.

Step 2

Remove outer cap by twisting it to the right.

Step 3

Wash your hands well.
Shake the bottle for 2 to 3 seconds before using.

Step 4

Remove the inner pink cap. Don't allow the dropper tip to touch any surface.

Step 5

Put 1 to 2 drop(s) into
the affected eye.

Step 6

Put pink cap back
onto the bottle.

Step 7

If wearing contact lenses, wait 15 minutes before putting them back in.

Instructions For Use

How often can I use EYSUVIS?

EYSUVIS can be used up to 4 times a day, putting 1 or 2 drops into the affected eye as directed by your eye doctor.

You can start using EYSUVIS as soon as you feel symptoms flare up. Keep using it (at your eye doctor’s direction) for up to 2 weeks when you experience dry eye flares.

Make sure to refill your prescription so you can be prepared the next time symptoms flare up.

EYSUVIS® (loteprednol etabonate ophthalmic suspension) eyedropper

Can I still use my over‑the‑counter (OTC) drops?

Yes, you can. Although OTC drops aren’t designed to address the cause of your symptoms, they can still provide temporary relief. Just be sure to wait at least 5 minutes between using EYSUVIS and other eye drops.

Get Started

Contact us

For additional information or to report an adverse event, call Kala Pharmaceuticals, Inc. at 1‑833‑287‑KALA
(1‑833‑287‑5252).

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit , or call 1‑800‑FDA‑1088.

Sign up for updates

Want to know more about EYSUVIS? Register your email to get updates and information on the drop that’s there for the flare.

* In a clinical trial program with 2871 patients with dry eye, patients using EYSUVIS showed significant reduction in the symptoms of dry eye (ocular discomfort) as early as Day 4 after starting treatment (versus placebo). Symptoms continued to improve up to the end of the treatment period (Day 15). Patients taking EYSUVIS also showed significant reduction in signs of dry eye (eye redness) at Day 15 versus placebo.